43 research outputs found
Riqueza y rareza floriÌsticas en los afloramientos dolomiÌticos de las Cordilleras BeÌticas (sur de EspanÌa): ensayo preliminar.
RESUMEN. Riqueza y rareza florĂsticas en los afloramientos dolomĂticos de las Cordilleras BĂ©ticas (sur de España): ensayo preliminar. Sobre los afloramientos dolomĂticos de las Cordilleras BĂ©ticas se desarrollan comunidades vegetales muy especĂficas y ricas en endemismos. Dichas comunidades no han sido estudiadas desde un punto de vista conservacionista. Este trabajo aborda su distribuciĂłn, riqueza y grado de protecciĂłn actuales permitiendo evaluar la eficacia de la red de espacios protegidos. Para ello, se ha creado una base de datos de presencia/ausencia de dolomitĂłfilos en cuadrĂculas UTM de 10 km. de lado que han sido definidas como unidades geogrĂĄficas operacionales (UGOs). Posteriormente, se ha evaluado la riqueza, la rareza en continuo y la rareza en discontinuo de las UGOs. Los resultados obtenidos han subrayado la importancia del sector Malacitano-Almijarense de la provincia BĂ©tica (en especial la zona del Trevenque) como centro de riqueza y endemicidad de dolomitĂłfilos. Por otra parte, la red de espacios naturales abarca casi la totalidad de las localidades de mayor interĂ©s en la Comunidad AutĂłnoma de AndalucĂa, mientras que tiene importantes lagunas en la RegiĂłn de Murcia y en la provincia de Albacete (perteneciente a la Comunidad AutĂłnoma de Castilla-La Mancha).Palabras clave. DolomitĂłfilo, dolomĂas, selecciĂłn de reservas, endemismo, espacios naturales protegidos, flora.ABSTRACT. Floral richness and rarity in the dolomitic outcrops of the Baetic Ranges (southern Spain): a preliminary essay. The dolomitic areas of the Baetic Ranges house extremely peculiar plant communities. These communities are diverse and especially rich in endemic species. The vegetation and flora of the dolomitic outcrops have not been studied from a conservation point of view. This work is focused on the distribution, richness and current level of protection of these areas, consequently, it allows us to evaluate the efficacy of the protected areas network. In order to meet this goal, a âpresence/absenceâ database of the dolomitic taxa has been carried out, according to UTM cells sized an area of 10 Ă 10 km. These cells have been used as âOperational Geographic Unitsâ (OGUâs). In due course, the richness, the continuous and discontinuous rarity of every OGU have been evaluated. The results depicted the great importance of the Malacitano-Almijarense sector of the Baetic province (especially where the Trevenque mountain is located) as a spot of richness and endemicity of dolomitic taxa. In addition, the protected areas network appears to be quite efficient in meeting conservation objectives in the Region of Andalusia, whilst it is clearly deficient in the Region of Murcia and the Province of Albacete (included in the Region of Castilla-La Mancha).Key words. Dolomitic species, dolomites, selection of reserves, endemism, natural protected areas, flora
Recensiones [Revista de Historia Económica Año XIV Primavera-Verano 1996 n. 2 pp. 477-528]
Editada en la FundaciĂłn Empresa PĂșblicaBeatriz CĂĄrceles de Gea. Fraude y administraciĂłn fiscal en Castilla La ComisiĂłn de Millones (1632-1658): Poder fiscal y privilegio jurĂdico-polĂtico (Por Juan Zafra Oteyza).-- Enric Tello. Cervera i la Segarra al segle XVIII. En els origens d`una Catalunya pobra, 1700-1860 (Por TomĂĄs Peris Albentosa).-- Ăngela Atienza. Propiedad y SeñorĂo en AragĂłn. El clero regular entre la expansiĂłn y la crisis (1700-1835) (Por JosĂ© Manuel Latorre Ciria).-- Michel Zylberberg. Une si duouce domination. Les milieux d'affaires français et l`Espagne vers 1780-1808 (Por Joan Caries MaixĂ© Altes).-- Paloma Pastor Rey de Viñas. Historia de la FĂĄbrica de Cristales de San Ildefonso durante la Ă©poca de la IlustraciĂłn (1727-1810) (Por Juan Helguera Quijada).-- Ricardo Robledo HernĂĄndez. Economistas y reformadores españoles: La cuestiĂłn agraria (1760-1935) (Por Juan Antonio Carmona Pidal).-- Juan Pan Montojo. La bodega del mundo (1800-1936) (Por JosĂ© Pujol AndrĂ©u).-- MoisĂ©s LlordĂ©n Miñambres. Desarrollo econĂłmico y urbano de GijĂłn en los siglos XIX y XX (Por Carlos Larrinaga RodrĂguez).-- Manuel Montero. La California del hierro. Las minas y la modernizaciĂłn econĂłmica y social de Vizcaya (Por Antonio Escudero).-- Salvador Cruz Artacho. Caciques y campesinos. Poder polĂtico, modernizaciĂłn agraria y conflictividad rural en Granada. 1890-1923 (Por Luis Garrido GonzĂĄlez).-- Miguel Muñoz Rubio. Renfe (1941-1991). Medio siglo de ferrocarril pĂșblico (Por Francisco Javier Vidal Olivares).-- Eric Hobsbawn. Historia del siglo XX. 1914-1991 (Por Gabriel Tortella).-- Marjorie Grice-Hutchinson. Ensayos sobre el pensamiento econĂłmico en España (Por JosĂ© Luis GarcĂa Ruiz).-- Richard N. Langlois y Paul L. Robertson. Firms, Markets and Economic Change. A Dynamic Theory of Business Institutions (Por JesĂșs M. Valdaliso).-- John Komlos (ed.). Stature, Living Standards, and Economic Development: Essays in Anthropometric History, y John Komlos (ed.). The Biological Standard of Living on Three Continents: Further Explorations in Anthropometric History (Por James Simpson)Publicad
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters.
Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs).
Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001).
Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio
CIBERER : Spanish national network for research on rare diseases: A highly productive collaborative initiative
Altres ajuts: Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovación.CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research
Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic
This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic